Mad Money w/ Jim Cramer 3/19/26 — Episode Summary
Date: March 19, 2026
Host: Jim Cramer
Podcast: Mad Money w/ Jim Cramer (CNBC)

Episode Overview

This episode of Mad Money features Jim Cramer analyzing the market volatility spurred by geopolitical tensions and a spike then pullback in oil prices. Cramer explores how oversold conditions and investor bearishness might set the stage for a rebound, walks through key sentiment indicators, and comments on strategies for buying in bear markets. He dives into company-specific stories including Five Below’s surprise breakout quarter, Johnson & Johnson’s big FDA approval, and Signet Jewelers’ turnaround. The listener call-in “Lightning Round” segment offers rapid-fire buy/sell takes on several stocks. Throughout, Jim emphasizes strategy, history, and temperament as keys to winning during turbulent markets.

Market Turmoil and Opportunity: Oversold Conditions (00:45–08:09)

• Main Theme:
  Turbulent geopolitical events (notably Israeli and Iranian strikes affecting energy facilities) sent global oil and gas prices higher, contributing to a major market selloff—which then sharply reversed by the session’s end as oil prices pulled back.

• Key Points:

  • The market is now oversold, possibly signaling a bottom and a “hold your nose and buy” opportunity.
  • Sentiment indicators:
    • AAII Poll: Extremely bearish sentiment—52% bearish, just 30% bullish.
    • CNN Fear & Greed Index: In “extreme fear.”
    • MarketEdge Oscillator: “Minus 7.5”—deeply oversold territory. (“At these levels, the odds now favor the bulls, which is one reason why I think we rebounded in the afternoon.” [07:00])
  • Historic analysis: Oversold readings this deep typically yield strong 30-day gains—except during genuine systemic crises (1987 crash, 2008 financial crisis).

• Quotes:

  • “Sometimes you just have to hold your nose and buy.” (00:54)
  • “There are far more bears than bulls. That matters because when just about everyone's already bearish, there’s nobody left to sell.” (02:45)
  • “As a rule, you have to buy something when the oscillator gets this oversold. You do.” (07:30)

Lightning Round #1 & Stock Takes (08:09–09:39)

• Notable Q&A:
  • Reddit (RDDT): Cramer expresses surprise at the stock’s swoon, calling Reddit “an incredibly valuable property… I’d like to buy some stock right here at 27 times earnings.” (08:36)
  • Market Recap: Reiterates history’s bullish precedent for post-oversold rebounds.

Five Below: Retail Turnaround Star (11:35–18:27)

• Deep Dive:

  • Five Below exceeded expectations with a “monster move.” Sales growth beat, EPS beat, and—crucially—guidance blew away analyst projections.
  • Why the outperformance? New CEO Winnie Park described as a “miracle worker,” refocused on core Gen Alpha, Gen Z, and Millennial moms, and aggressively embraced social media marketing and merchandise integration.
  • Operational Shift: Higher-priced items are now merchandised alongside lower-priced options, sparking increased basket size and improved toy sales.

• Quotes:

  • “They delivered 15.4% [same-store sales growth]. Net sales came in higher than expected, up more than 24% year over year.” (13:20)
  • Winnie Park: “We made a fundamental shift in how we operate, how we engage with our customers and how we strategize and deliver growth of the business and the brand.” (15:23)
  • Cramer: “This turnaround is all about management. Under the leadership of Winnie Park, Five Below has become a company that knows its target customer and is serving that customer incredibly well.” (17:42)

• Notable Moment:
  Cramer credits social media strategy and nimbleness in following (and amplifying) youth-driven trends—e.g., the “squishy dumpling craze.”

Johnson & Johnson: FDA Approval and Market Overlook (20:03–26:47)

• Key Discussion:

  • J&J’s FDA approval for icotide, a pill (not injection) for moderate to severe plaque psoriasis, is “huge.” Yet, the stock barely budged due to macro headwinds.
  • Oral form is a game-changer—patients prefer pills to injections; competitor AbbVie’s injectable Skyrizi generated $17.5B in sales, and J&J’s oral could disrupt this market.
  • Legal risk from baby powder lawsuits is fading, and a planned spinoff of slower-growing orthopedics division could unlock value.
  • Street estimates of $5–7.5B peak sales for new drug are “very reasonable” (Cramer thinks even higher potential).

• Quotes:

  • “A terrible, horrible, no good, very bad day for the averages creates buying opportunities for you. I think we're getting one right now in Johnson & Johnson.” (20:17)
  • “We don't yet know how it will compare to the two injections on cost… but even if it comes at a similar price… people prefer a pill to an injection.” (23:18)
  • “This was genuine positive development that absolutely did nothing for the share price because of what’s happening in Iran.” (25:28)

Lightning Round #2 & Listener Q&A (26:47–37:22)

• Intuitive Surgical (ISRG):
  Most important metric? Cramer: “Hospital utilization.” Cautions stock multiple is too high despite good earnings. (26:59)
• Booking Holdings:
  Cramer recommends waiting at least four weeks after the 25-to-1 stock split, as such splits usually cause churning and near-term volatility. Still likes the company. (28:15)
• Signet Jewelers (Special Segment):

  • Interview with CEO JK Semantics (30:03–37:17):

    • Signet’s focus on four core brands (K, Zales, Jared, Banter) drove success.
    • Balanced mix of natural and lab-grown diamonds; lab-grown penetration is rising, especially with fashion-focused consumers.
    • Digital investment and in-store experience top strategic priorities.
    • Strong free cash flow gives room for buybacks, dividends, and reinvestment.

  • Quote, JK Semantics:

    • “If the core is healthy, then the rest of the business works better.” (30:44)
    • “Lab grown diamond fashion growth… is higher because there’s an affordability and accessibility gem that wasn’t there before with natural diamond.” (33:50)
    • Cramer: “This is a different company from the way it was. Congratulations.” (37:15)

The Lightning Round: Rapid-Fire Stock Calls (37:22–41:36)

Sample Buy/Sell Blurbs:

• ImmunityBio: Wait and see—recent “magical thinking” and big share block needs to stabilize. (38:34)
• Skyworks: Too reliant on cell phones, needs to merge—neutral/slightly negative. (39:08)
• Stellantis: New 52-week low; Cramer sees no reason to own it—negative. (39:36)
• Element Solutions: Interesting specialty chemicals play, worth further research. (40:01)
• GE Verona: “The best book of business… almost every data center needs gas turbines”—positive. (40:35)
• Carnival (CCL): Upgraded, bookings strong, remains inexpensive—positive. (41:21)

Closing Segment: The Art of Buying into Selloffs (41:49–47:11)

• Lesson:
  Buying high-quality companies while in free fall is emotionally difficult but often rewarding. Cramer illustrates with the Dell Technologies plunge—ignoring panic, buying on the way down, and pyramiding in if the thesis holds.

• Quote:

  • “Nothing’s harder than buying a stock when it’s in a tailspin…But with a fine company like Dell…you can get incredible bargains if you’re simply willing to buy the stock at moments where it’s wrongly hated.” (44:06)
  • “If you waited to buy the stock until the coast was clear…the coast never goes clear. It’s not the way it works. You’ll miss the move.” (45:23)

Notable Quotes—Greatest Hits

• “I promise to help you find [a bull market]... Other people make friends. I’m just trying to make a little bit of money.” (00:45)
• Winnie Park (Five Below CEO): “Our maniacal focus on our target customer has pushed us to be more agile…communicating with our customers in the social media channels they live in.” (15:40)
• “I like to say there’s always more markets…My job is to help you find them, right here.” (46:43)

Timestamps for Important Segments

| Time | Segment | Notes / Quotes | |------------|----------------------------------|--------------------------------------------| | 00:45 | Market/Opening Commentary | Oversold signals, history lessons | | 08:09 | Lightning Round #1/Reddit call | “I’d like to buy some Reddit here…” | | 11:35 | Five Below Deep Dive | CEO turnaround, social media focus | | 20:03 | Johnson & Johnson FDA approval | J&J’s oral psoriasis drug | | 26:47 | Lightning Round #2/Listener Q&A | ISRG, Booking Holdings, fundamentals talk | | 30:03 | Signet Jewelers CEO Interview | Brand & strategy focus | | 37:22 | Lightning Round | ImmunityBio, Skyworks, Stellantis, etc. | | 41:49 | Dell Example: Buy the Drop | Pyramid buying strategy |

Tone and Style

Cramer’s signature fiery, rapid-paced, and enthusiastic delivery is present throughout. He balances humor (“it’s retail, 101 people!”), calls for discipline, and empathetic understanding of how hard it is to buy when there's blood in the streets. The episode is a mix of practical investing tactics, breaking news interpretation, and colorful, plainspoken advice.

Summary Takeaway

Jim Cramer guides listeners through volatile markets, urges disciplined buying in oversold conditions, and spotlights winning management and strategy in companies like Five Below and Johnson & Johnson. The episode underscores the value of contrarian thinking, rigorous homework, and emotional fortitude when taking buy-the-dip opportunities—while never forgetting fundamentals and management quality.